Indian equities advanced for a fourth straight session as easing geopolitical tensions, lower crude oil prices, softer bond yields and a st...

LIC CEO R Doraiswamy stated the corporation will maintain its leadership in the life insurance sector and contribute to national developmen...

India's economy shows steady growth driven by domestic demand. The West Asia conflict presents challenges like higher oil prices. The gover...

India's government is set to accelerate reforms, focusing on attracting foreign investment and divesting assets. This strategy aims to main...

India's economy is navigating external challenges like rising import costs. However, domestic consumption remains strong, ensuring growth m...

Subahoo Chordia, a key figure at Edelweiss Alternatives, has departed to launch his own infrastructure fund. He was instrumental in buildin...

The government plans to sell up to a 2% stake in LIC, potentially raising Rs 10,000 crore. This move aims to deepen public shareholding ami...

Hitachi Energy India is set to inject Rs 2,000 crore into expanding its manufacturing capabilities, driven by the surging demand for power ...

Foreign institutional investors are strategically buying into beaten-down smallcap stocks in India, increasing stakes in 54 companies despi...

Finance Minister Nirmala Sitharaman is preparing new reforms to ease business compliance. She believes strong domestic consumption will hel...

Finance Minister Nirmala Sitharaman pledges government support for farmers facing rising costs. She encourages Indian businesses to invest ...

Finance Minister Nirmala Sitharaman pledged government support for farmers facing rising input costs. She urged Indian industry to expand a...

Senior citizens seeking stable returns and capital safety find fixed deposits a preferred investment. For a 3-year tenure, small finance ba...

Wipro has undoubtedly done a good job in the past 6-7 quarters in client mining (increase in $50 million/$100 million clients).

It is a cash flow business and there is a re-rating that can happen in midcap.

Mastek is consolidating so that could be interesting over the next one year.

Midcap pharma stocks tends to be a little volatile in a three year time frame that said in the current buoyant environment.